- $1.53bn
- $1.48bn
- $2.03bn
- 72
- 51
- 15
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.05 | ||
| PEG Ratio (f) | 0.72 | ||
| EPS Growth (f) | 41.68% | ||
| Dividend Yield (f) | 0.05% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.15 | ||
| Price to Tang. Book | 8.75 | ||
| Price to Free Cashflow | 34.72 | ||
| Price to Sales | 0.75 | ||
| EV to EBITDA | 12.54 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.11% | ||
| Return on Equity | 6.5% | ||
| Operating Margin | 4.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 687.18 | 773.91 | 1,144.16 | 1,386.66 | 2,034.54 | 2,728.88 | 3,309.92 | 29.41% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +137.78 | +63.99 | -25.41 | +9.65 | -34.38 | +48.09 | +32.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services.
Directors
- Kenneth Sim CHM (67)
- Thomas Lam PRE (71)
- Brandon Sim CCE (28)
- Eric Chin CFO (41)
- Albert Young CAD (74)
- Adrian Vazquez OTH (51)
- Mitchell Kitayama LED (64)
- Weili Dai DRC (57)
- J. Lorraine Estradas DRC
- Linda Marsh DRC (71)
- Matthew Mazdyasni DRC (64)
- Ernest Bates IND (84)
- John Chiang IND (58)
- Michael Eng IND (74)
- Mark Fawcett IND
- David Schmidt IND (73)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 18th, 2008
- Public Since
- April 9th, 1999
- No. of Shareholders
- 662
- No. of Employees
- 1,900
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 50,119,701
- Address
- 1668 S. Garfield Avenue, 2Nd Floor, ALHAMBRA, 91801
- Web
- https://www.astranahealth.com/
- Phone
- +1 6262820288
- Auditors
- Ernst & Young LLP
Upcoming Events for ASTH
Q1 2025 Astrana Health Inc Earnings Call
Astrana Health Inc at Bank of America Global Healthcare Conference
Astrana Health Inc Annual Shareholders Meeting
Astrana Health Inc Annual Shareholders Meeting
Q2 2025 Astrana Health Inc Earnings Release
Similar to ASTH
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
BRK International Holding
NASDAQ Capital Market
FAQ
What is the Astrana Health share price?
As of Today at 19:23 UTC, shares in Astrana Health are trading at $30.60. This share price information is delayed by 15 minutes.
How has the Astrana Health share price performed this year?
Shares in Astrana Health last closed at $30.60 and the price had moved by -16.3% over the past 365 days. In terms of relative price strength the Astrana Health share price has underperformed the S&P500 Index by -22.74% over the past year.
What are the analyst and broker recommendations for Astrana Health?
The overall consensus recommendation for Astrana Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Astrana Health dividend yield?
Astrana Health does not currently pay a dividend.
Does Astrana Health pay a dividend?
Astrana Health does not currently pay a dividend.
When does Astrana Health next pay dividends?
Astrana Health does not currently pay a dividend.
How do I buy Astrana Health shares?
To buy shares in Astrana Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Astrana Health?
As of the previous close price of $30.60, shares in Astrana Health had a market capitalisation of $1.53bn.
Where are Astrana Health shares listed?
Here are the trading details for Astrana Health:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ASTH
What kind of share is Astrana Health?
Based on an overall assessment of its quality, value and momentum Astrana Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Astrana Health share price forecast for 2025?
The analyst consensus target price for shares in Astrana Health is $50.50. That is 65.03% above the last closing price of $30.60.
Analysts covering Astrana Health currently have a consensus Earnings Per Share (EPS) forecast of $1.32 for the next financial year.
Find out moreWhat is the trend in the Astrana Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Astrana Health. Over the past six months, its share price has underperformed the S&P500 Index by -42.08%.
As of the last closing price of $30.60, shares in Astrana Health were trading -28.07% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Astrana Health PE Ratio?
The Astrana Health PE ratio based on its reported earnings over the past 12 months is 21.05. The shares last closed at $30.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Astrana Health?
Astrana Health's management team is headed by:
- Kenneth Sim - CHM
- Thomas Lam - PRE
- Brandon Sim - CCE
- Eric Chin - CFO
- Albert Young - CAD
- Adrian Vazquez - OTH
- Mitchell Kitayama - LED
- Weili Dai - DRC
- J. Lorraine Estradas - DRC
- Linda Marsh - DRC
- Matthew Mazdyasni - DRC
- Ernest Bates - IND
- John Chiang - IND
- Michael Eng - IND
- Mark Fawcett - IND
- David Schmidt - IND